MADRIGAL PHARMACEUTICALS INC's ticker is and the CUSIP is 558868905. A total of 7 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,788,224 | -46.8% | 265,600 | -15.8% | 0.01% | -48.0% |
| Q2 2023 | $72,857,400 | +59.9% | 315,400 | +67.7% | 0.02% | +31.6% |
| Q1 2023 | $45,569,106 | -41.0% | 188,100 | -29.3% | 0.02% | -47.2% |
| Q4 2022 | $77,206,500 | +2701.4% | 266,000 | +527.4% | 0.04% | +3500.0% |
| Q3 2022 | $2,756,000 | -43.1% | 42,400 | -37.4% | 0.00% | -50.0% |
| Q2 2022 | $4,846,000 | – | 67,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 202 | $4,326,000 | 0.43% |
| SABBY MANAGEMENT, LLC | 154 | $3,298,000 | 0.42% |
| SIMPLEX TRADING, LLC | 57 | $1,220,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,000 | $428,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |